Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Lim, K. Wong, C. Lau (1997)
Parvovirus B19 infection in Hong Kong.The Journal of infection, 35 3
G. Serjeant, K. Mason, J. Topley, B. Serjeant, J. Pattison, S. Jones, R. Mohamed (1981)
OUTBREAK OF APLASTIC CRISES IN SICKLE CELL ANAEMIA ASSOCIATED WITH PARVOVIRUS-LIKE AGENTThe Lancet, 318
R. Ahmad, Goldsmith Hj (1976)
RE-USE OF DISPOSABLE DIALYSERSThe Lancet, 307
Copland Jg, Davies Ct (1964)
SPREAD OF VIRUS HEPATITIS.The Lancet, 1
M. Musiani, M. Zerbini, G. Gentilomi, G. Rodorigo, V. Rosa, D. Gibellini, S. Venturoli, G. Gallinella (1995)
Persistent B19 parvovirus infections in hemophilic HIV‐1 infected patientsJournal of Medical Virology, 46
P. Mortimer, N. Luban, J. Kelleher, B. Cohen (1983)
TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 322
G. Siegl, R. Bates, K. Berns, B. Carter, D. Kelly, E. Kurstak, P. Tattersall (1985)
Characteristics and taxonomy of Parvoviridae.Intervirology, 23 2
K. Brown, N. Young, J. Liu (1994)
Molecular, cellular and clinical aspects of parvovirus B19 infection.Critical reviews in oncology/hematology, 16 1
A. Poblotzki, A. Gigler, B. Lang, H. Wolf, S. Modrow (1995)
Antibodies to parvovirus B19 NS-1 protein in infected individuals.The Journal of general virology, 76 ( Pt 3)
T. Schwarz, M. Roggendorf, F. Deinhardt (2008)
[Incidence of parvovirus B19 infection. Seroepidemiologic studies].Deutsche medizinische Wochenschrift, 112 40
Y. Cossart, B. Cant, A. Field, D. Widdows (1975)
PARVOVIRUS-LIKE PARTICLES IN HUMAN SERAThe Lancet, 305
T. Nunoue, T. Nunoue, K. Okochi, K. Okochi, P. Mortimer, P. Mortimer, B. Cohen, B. Cohen (1985)
Human parvovirus (B19) and erythema infectiosum.The Journal of pediatrics, 107 1
J. Pattison, S. Jones, J. Hodgson, L. Davis, J. White, C. Stroud, L. Murtaza (1981)
PARVOVIRUS INFECTIONS AND HYPOPLASTIC CRISIS IN SICKLE-CELL ANAEMIAThe Lancet, 317
R. Shade, M. Blundell, S. Cotmore, P. Tattersall, C. Astell (1986)
Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisisJournal of Virology, 58
M. Williams, B. Cohen, A. Beddall, K. Pasi, P. Mortimer, F. Hill (1990)
Transmission of Human Parvovirus B19 by Coagulation Factor ConcentratesVox Sanguinis, 58
W. Paver, S. Clarke (1976)
Comparison of human fecal and serum parvo-like virusesJournal of Clinical Microbiology, 4
Anderson Anderson (1990)
Human parvovirusJournal of Infectious Disease, 161
D. Reid, T. Brown, T. Reid, J. Rennie, C. Eastmond (1985)
HUMAN PARVOVIRUS-ASSOCIATED ARTHRITIS: A CLINICAL AND LABORATORY DESCRIPTIONThe Lancet, 325
N. Okabe, S. Koboyashi, O. Tatsuzawa, P. Mortimer (1984)
Detection of antibodies to human parvovirus in erythema infectiosum (fifth disease).Archives of Disease in Childhood, 59
A. Couroucé, F. Ferchal, A. Muller, Soulier Jp, F. Morinet, J. Drouet, Y. Pérol (1984)
HUMAN PARVOVIRUS INFECTIONS IN FRANCEThe Lancet, 323
Tamara Brown, A. Anand, L. Ritchie, J. Clewley, T. Reid (1984)
INTRAUTERINE PARVOVIRUS INFECTION ASSOCIATED WITH HYDROPS FETALISThe Lancet, 324
G. Kurtzman, B. Cohen, A. Field, R. Oseas, R. Blaese, N. Young (1989)
Immune response to B19 parvovirus and an antibody defect in persistent viral infection.The Journal of clinical investigation, 84 4
L. Larsson (1976)
HUMAN PANCREATIC POLYPEPTIDE, VASOACTIVE INTESTINAL POLYPEPTIDE, AND WATERY DIARRHŒA SYNDROMEThe Lancet, 308
Schwarz Schwarz, Roggerdorf Roggerdorf, Deinhardt Deinhardt (1987)
Prevalence of parvovirus B19 infection: a seroepidemiological studyDeutsch Medicine Wochenschr, 112
Matsunaga Matsunaga, Takeda Takeda, Yamazaki Yamazaki, Kamata Kamata, Kurosana Kurosana (1995)
Seroepidemiology of human parvovirus B 19 using recombinant VP1 + VP2 particle antigen (Japanese)Kansenshogaku Zasshi, 69
K. Brown, S. Anderson, N. Young (1993)
Erythrocyte P antigen: cellular receptor for B19 parvovirus.Science, 262 5130
K. Yamashita, Yasuko Matsunaga, Jean Taylor-Wiedeman, Shudo Yamazaki (1992)
A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade.Japanese journal of medical science & biology, 45 2
B. Cohen, M. Buckley (1988)
The prevalence of antibody to human parvovirus B19 in England and Wales.Journal of medical microbiology, 25 2
Edwards Edwards, Kessel Kessel, Gardner Gardner, Eaton Eaton, Pollock Pollock, Fleck Fleck, Gibson Gibson, Woodroof Woodroof, Porter Porter (1981)
A search for a characteristic illness in children with serological evidence of viral or toxoplasma infection: Epstein‐Barr virus, hepatitis A virus, human polyomaviruses BK and JC, parvovirus‐like B 19 and toxoplasmaJ Infect, 3
P. Knott, G. Welply, M. Anderson (1984)
Serologically proved intrauterine infection with parvovirus.British Medical Journal (Clinical research ed.), 289
K. Rao, A. Patel, M. Anderson, J. Hodgson, S. Jones, J. Pattison (1983)
Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia.Annals of internal medicine, 98 6
D. White, D. White, P. Mortimer, P. Mortimer, D. Blake, D. Blake, A. Woolf, A. Woolf, B. Cohen, B. Cohen, P. Bacon, P. Bacon (1985)
HUMAN PARVOVIRUS ARTHROPATHYThe Lancet, 325
M. Anderson, S. Jones, S. Fisher-Hoch, E. Lewis, S. Hall, C. Bartlett, B. Cohen, P. Mortimer, M. Pereira (1983)
HUMAN PARVOVIRUS, THE CAUSE OF ERYTHEMA INFECTIOSUM (FIFTH DISEASE)?The Lancet, 321
P. Cassinotti, G. Burtonboy, M. Fopp, G. Siegl (1997)
Evidence for persistence of human parvovirus B19 DNA in bone marrowJournal of Medical Virology, 53
Yasuko Matsunaga, Naokazu Takeda, Shudo Yamazaki, Kunio Kamata, Daisuke Kurosawa (1995)
組換え (VP1+VP2) 粒子抗原を用いたヒトパルボウイルスB19の血清疫学The Journal of the Japanese Association for Infectious Diseases, 69
Larry Anderson, C. Tsou, Robert Parker, Terence Chorba, H. Wulff, P. Tattersall, P. Mortimer (1986)
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assayJournal of Clinical Microbiology, 24
Chiu-Hwa Wang, Chien-Jen Chen, Chung‐Yi Hu, S. You, C. Chu, M. Chou, M. Essex, W. Blattner, Chen‐Hui Liu, Czau-siung Yang (1988)
Seroepidemiology of human T-cell lymphotropic virus type I infection in Taiwan.Cancer research, 48 17
Pattison Pattison (1994)
Human parvovirus B19Lancet, 308
D. Erdman, B. Anderson, T. Török, T. Finkel, L. Anderson (1997)
Possible transmission of parvovirus B19 from intravenous immune globulinJournal of Medical Virology, 53
J. Edwards, I. Kessel, S. Gardner, B. Eaton, T. Pollock, D. Fleck, P. Gibson, M. Woodroof, A. Porter (1981)
A search for a characteristic illness in children with serological evidence of viral or toxoplasma infection.The Journal of infection, 3 4
Anne Gray, L. Guillou, J. Zufferey, F. Rey, A. Kurt, P. Jichlinski, H. Leisinger, J. Benhattar (1998)
Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumours.The Journal of general virology, 79 ( Pt 3)
Bender Ae (1974)
Letter: Protein requirement.The Lancet, 2
N. Breslow, N. Day, W. Davis (1980)
Statistical methods in cancer research: volume 1- The analysis of case-control studiesIARC scientific publications, 32
In order to determine the prevalence and risk factors of human parvovirus B19 (B19) infection in Taiwan, a seroepidemiological study was carried out in 19 townships. Serum samples were collected from 862 healthy residents, who were selected by stratified random sampling from various study areas. They were chosen from four different ethnic groups including aborigines, Fukien Taiwanese, Hakka Taiwanese, and mainland Chinese. Serum samples were screened for B19 IgG antibody by indirect antibody capture enzyme‐linked immunosorbent assay (ELISA) and B19 IgM by IgM antibody capture (MAC)‐ELISA, respectively. The overall prevalence of anti‐B19 IgG and anti‐B19 IgM was 32.8% and 0.35%, respectively. The anti‐B19 seropositive rate in females was significantly higher than that of males (36.4% vs. 29.4%, P < .001). The age‐sex‐adjusted seropositive rate in urban townships (39.9%) was higher than that in aboriginal townships (30.5%, P < .001). The seropositive rate increased significantly with age showing a dose–response relationship (P = 0.0001 based on a trend test). Blood transfusion was found to be associated with an increased seropositive rate showing a multivariate‐adjusted odds ratios of 1.6. J. Med. Virol. 57:169–173, 1999. © 1999 Wiley‐Liss, Inc.
Journal of Medical Virology – Wiley
Published: Feb 1, 1999
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.